Skip to main content
RNAZ logo

RNAZ

Transcode Therapeutics, Inc.
$8.61 +0.96 (+12.55%) At close · Jul 2
Market Cap
$8.18M
Shares
950,302

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 8
Total Value: $265,743
Total Shares: 30,865

Institutional Ownership Trend

4 quarters

Holder Concentration

Across 8 13F filers · Δ vs Dec 31, 2025
Top Holder
41.3%
Jun 2025 → Mar 2026 · range 41.3% – 92.3%
−35.1 pts
Top 5
99.8%
Jun 2025 → Mar 2026 · range 99.8% – 99.9%
−0.2 pts
Top 10
100.0%
Jun 2025 → Mar 2026 · range 100.0% – 100.0%
0.0 pts
HHI
2,970
Jun 2025 → Mar 2026 · range 2,970 – 8,541
Highly concentrated−3,390

Quarterly Activity

vs Dec 31, 2025
New
4
Increased
2
Decreased
1
Sold Out
2
Unchanged
1
Holder count: +2
Institutional value: +903.0%
Shares held: +695.5%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 8 of 8
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1829635 CUSIP 89357L501 Visit website Investor relations